XEN-D0501
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for XEN-D0501, covering 2015-07-15 to 2022-04-29. Get the full timeline:
Most recent: Clinical Trial Update: A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Diabetes [Phase 2]